|
Sustained, target delivery for treatment of cervical pathologies
|
1R43CA162417-01A1
|
$253,110
|
$253,110
|
Spencer, WENDY
|
3P BIOTECHNOLOGIES, INC.
|
|
Prevention of Tumor Recurrence Following Surgical Resection (Phase II)
|
6R44CA135967-03
|
$498,107
|
$498,107
|
Wolinsky, Jesse
|
ACUITYBIO CORPORATION
|
|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
5R01CA148966-03
|
$804,139
|
$804,139
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$225,445
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$15,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$15,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$4,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Eleventh Annual AACR International Conference on Frontiers in Cancer Prevention R
|
1R13CA174376-01
|
$25,000
|
$25,000
|
Foti, Margaret
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Community Clinical Oncology Program
|
5U10CA037422-25
|
$4,499,349
|
$359,948
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Prevention of EtOH-induced promotion of hepatocarcinogenesis by genistein/soy
|
1R21CA169389-01
|
$193,140
|
$193,140
|
Ronis, Martin
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$38,893
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Translational Research in Breast Cancer
|
5P50CA058183-18
|
$2,262,139
|
$452,428
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
$48,640
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-03
|
$350,219
|
$87,555
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Tanshinones for prevention of bladder cancer progression
|
5R03CA159348-02
|
$87,000
|
$87,000
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S1
|
$300,000
|
$24,000
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S2
|
$139,989
|
$11,199
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
5U10CA139519-03
|
$310,336
|
$24,827
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$32,472
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing disease and treatment response in colon cancer chemoprevention
|
5K05CA131504-05
|
$163,042
|
$163,042
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
$182,896
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-21
|
$1,813,397
|
$1,813,397
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Plasma Lipid Markers and Cancer Risk
|
1R03CA159399-01A1
|
$88,104
|
$44,052
|
Lin, Jennifer
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
3U01CA138962-04S1
|
$167,479
|
$167,479
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-04
|
$1,548,411
|
$1,548,411
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-13
|
$4,908,989
|
$343,629
|
Stampfer, Meir
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-29
|
$728,213
|
$58,257
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
5U54CA163060-02
|
$1,174,448
|
$70,467
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identification of the molecular mechanism of a potent chemopreventive agent, CDDO
|
5F31CA134211-04
|
$43,601
|
$43,601
|
Gatbonton, Tonibelle
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S3
|
$4,849,180
|
$290,951
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S4
|
$74,396
|
$4,464
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Oncology Research Career Development Program (CORP)
|
5K12CA076917-15
|
$691,125
|
$69,113
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Molecular Mechanisms of Prostate Cancer Chemoprevention by Apigenin
|
5R01CA108512-08
|
$238,800
|
$238,800
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
5P50CA150964-02
|
$2,250,301
|
$202,527
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Effect of Rhamnetin on Oxidative Stress and Prostate Cancer
|
1R03CA166231-01A1
|
$78,500
|
$78,500
|
Shukla, Sanjeev
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Triterpenoid Modulators of Inflammatory Driven Carcinogenesis
|
5R01CA157735-02
|
$316,373
|
$316,373
|
Tochtrop, Gregory
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-23
|
$326,434
|
$26,115
|
Wilbur, Deborah
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention
|
5R01CA142879-03
|
$323,047
|
$323,047
|
Epstein, Ervin
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
S1P Lyase in colon cancer
|
3R01CA129438-05S1
|
$61,560
|
$15,390
|
SABA, JULIE
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
Controlling cancer with aspirin-triggered stimulation of resolution
|
1R01CA170549-01
|
$384,219
|
$384,219
|
Panigrahy, Dipak
|
CHILDREN'S HOSPITAL BOSTON
|
|
Community Clinical Oncology Program Research Base
|
2U10CA095861-11
|
$1,608,610
|
$128,689
|
POLLOCK, BRAD
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
2U10CA045418-26
|
$1,423,934
|
$113,915
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Cancer Center Support Grant
|
3P30CA033572-29S1
|
$91,911
|
$2,757
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S2
|
$139,999
|
$4,200
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S3
|
$75,000
|
$2,250
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-29
|
$2,225,352
|
$66,761
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction
|
5R01CA140245-03
|
$610,119
|
$610,119
|
PALOMARES, MELANIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Androgen Receptor-JunD Complex Inhibitors to Prevent Prostate Cancer Progression
|
1R43CA162734-01A1
|
$300,000
|
$300,000
|
BASU, HIRAK
|
COLBY PHARMACEUTICAL COMPANY
|
|
CCOP: Colorado Cancer Research Program
|
2U10CA067753-17
|
$1,128,806
|
$90,304
|
PAJON, EDUARDO
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Dietary Rice Bran Phytochemicals and Microbial Metabolites for Colon Chemoprevent
|
1R21CA161472-01A1
|
$190,441
|
$190,441
|
Weir, Tiffany
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
Total relevant funding to Chemoprevention for this search: $123,477,789
|